Evidence map›Paper›PMID 27251056›Full record

ArticleEndocrine pathology2016

Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients.

Felix Haglund, Stina Garvin, Catharina Ihre-Lundgren, Inga-Lena Nilsson, Evelina Hall, Tobias Carling, Anders Höög, C Christofer Juhlin

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Felix HaglundDepartment of Oncology-Pathology, Cancer Centre Karolinska, Karolinska Institutet, R8:04, 171 76, Stockholm, Sweden. Felix.Haglund@ki.se.
Stina GarvinDepartment of Clinical Pathology and Clinical Genetics and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Catharina Ihre-LundgrenDepartment of Molecular Medicine and Surgery, Karolinska Institutet and the Karolinska University Hospital, Stockholm, Sweden.
Inga-Lena NilssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet and the Karolinska University Hospital, Stockholm, Sweden.
Evelina HallDepartment of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Tobias CarlingDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Anders HöögDepartment of Oncology-Pathology, Cancer Centre Karolinska, Karolinska Institutet, R8:04, 171 76, Stockholm, Sweden.
C Christofer JuhlinDepartment of Oncology-Pathology, Cancer Centre Karolinska, Karolinska Institutet, R8:04, 171 76, Stockholm, Sweden. Christofer.Juhlin@ki.se.
Karolinska University Hospital · SEKarolinska Institutet · SELinköping University · SEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is a common endocrine malignancy, frequently presenting with lymph node metastasis at the time of diagnosis. Lymph node staging (N) partly determines treatment, follow-up, and prognosis. Since 2011, our institution has employed a more comprehensive histopathological work-up of lymph nodes in patients with PTC. We sought to retrospectively determine the value of serial lymph node level sectioning in PTCs with negative preoperative lymph node status (pN0) as a method to increase the sensitivity of detecting metastatic disease. We included all patients that underwent thyroidectomy and central neck dissection and subsequent comprehensive lymph node level sectioning due to PTC with an initial pN0 status between the years 2011 and 2015 at our institution. Sixty-seven cases of PTC with a median of 10 metastatic free lymph nodes identified per case were included. After serial lymph node sectioning of the central compartment, 11 cases (16 %) revealed lymph node metastasis, six of which (55 %) presented with a small primary tumor (<20 mm, T1). Of all T1 tumors with initial pN0 status, 18 % (T1a) and 9 % (T1b) reached a pN1 stage after comprehensive lymph node sectioning. Cases with altered lymph node status had a median of 15 identified lymph nodes as compared to ten in cases that remained negative. We conclude that comprehensive lymph node sectioning increased the sensitivity of detecting metastases in PTC and altered the pathological TNM staging (pTNM) for a significant number of patients. Although of limited prognostic significance, the method should be considered as an adjunct tool when assessing lymph node status of PTC as a part of the routine histological work-up to ensure an accurate cancer staging.

Indexed as

AdultCarcinomaCarcinoma, PapillaryFemaleHumansLymphatic MetastasisMaleMiddle AgedNeck DissectionNeoplasm StagingSpecimen HandlingThyroid Cancer, PapillaryThyroid NeoplasmsLevel sectioningLymph node stagingPapillary thyroid carcinomaPathologyTNM

Identifiers

PMID27251056
OpenAlexW2461315060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.